Marcus Skribek
Anknuten till Forskning
E-postadress: marcus.skribek@ki.se
Besöksadress: J6:20 BioClinicum, Akademiska stråket 1, 17164 Solna
Postadress: K7 Onkologi-Patologi, K7 Forskning Ekman, 171 77 Stockholm
Om mig
- För detaljerad information, se den engelska presentationssidan.
Artiklar
-
Article: ACTA ONCOLOGICA. 2023;62(12):1808-1814
-
Journal article: JOURNAL OF THORACIC ONCOLOGY. 2023;18(11):s638
-
Article: LUNG CANCER. 2022;166:132-134
-
Article: EUROPEAN JOURNAL OF CANCER. 2021;145:245-254
-
Article: CANCERS. 2020;12(12):E3707-3707
Alla övriga publikationer
-
Conference publication: JOURNAL OF THORACIC ONCOLOGY. 2023;18(11):s599
-
Review: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2023;11(3):e005841
-
Conference publication: JOURNAL OF THORACIC ONCOLOGY. 2023;18(11):S638
-
Conference publication: JOURNAL OF THORACIC ONCOLOGY. 2023;18(11):S599
-
Conference publication: ANNALS OF ONCOLOGY. 2022;33(7):S1087
-
Review: JOURNAL OF INTERNAL MEDICINE. 2022;291(6):732-754
Forskningsbidrag
-
Research GrantRadiumhemmets Forskningsfonder1 June 2022 - 31 May 2024
Anställningar
- Anknuten till Forskning, Onkologi-Patologi, Karolinska Institutet, 2023-2026
Gästforskning och resestipendier
- Clinical Research Fellow, Memorial Sloan Kettering Cancer Center, - Joined MSKCC to deepen expertise in oncology through firsthand learning of cancer management and treatment practices. - Collaborated with multidisciplinary teams to enhance patient outcomes and advance cancer care methodologies. - Specialized in radiotheranostics at the Jason Lewis Lab, integrating diagnostic imaging and targeted therapy to develop precision medicine approaches. - Involved in research focusing on DLL3 in small cell lung cancer and DLK1 in sarcoma, aiming to develop effective therapies for aggressive cancer types. - Worked under the supervision of industry-leading experts to pioneer novel cancer therapy methods., 2024-2024